Page last updated: 2024-09-05

sorafenib and Erythema

sorafenib has been researched along with Erythema in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	4 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Yao, CA	1
Cicek, D; Dagli, FA; Haligur, BD; Kandi, B; Karaoglu, A	1
Kung, EF; Maddox, JS; Petronic-Rosic, V; Sethi, A	1
Lipworth, AD; Robert, C; Zhu, AX	1
Amoh, Y; Eto, H; Iwamura, M; Katsuoka, K; Mii, S; Tanabe, K	1
Sahai, S; Swick, BL	1
Flaig, MJ; Prinz, JC; Rübsam, K; Ruzicka, T	1
Alexandrescu, DT; Dasanu, CA; Dutcher, J	1
Beldner, M; Burges, GE; Chaudhary, UB; Dewaay, D; Jacobson, M; Maize, JC	1
Bonomi, L; Imarisio, I; Paglino, C; Porta, C	1

Reviews

2 review(s) available for sorafenib and Erythema

Article	Year
Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Oncology, 2009, Volume: 77, Issue:5 Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Erythema; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Paresthesia; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Risk Factors; Sorafenib; Sunitinib; Syndrome	2009
Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib. Clinical and experimental medicine, 2007, Volume: 7, Issue:4 Topics: Acneiform Eruptions; Antineoplastic Agents; Benzenesulfonates; Erythema; Esophagitis; Exanthema; Humans; Hypertension; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib	2007

Article

Year

Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.

Oncology, 2009, Volume: 77, Issue:5

Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Erythema; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Paresthesia; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Risk Factors; Sorafenib; Sunitinib; Syndrome

2009

Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.

Clinical and experimental medicine, 2007, Volume: 7, Issue:4

Topics: Acneiform Eruptions; Antineoplastic Agents; Benzenesulfonates; Erythema; Esophagitis; Exanthema; Humans; Hypertension; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib

2007

Other Studies

8 other study(ies) available for sorafenib and Erythema

Article	Year
Sorafenib-induced erythema annulare centrifugum with spontaneous resolution after skin biopsy. The Australasian journal of dermatology, 2018, Volume: 59, Issue:2 Topics: Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Erythema; Humans; Immunohistochemistry; Leg Dermatoses; Liver Neoplasms; Male; Remission, Spontaneous; Skin Diseases, Genetic; Sorafenib	2018
Localized palmar-plantar epidermal hyperplasia associated with use of sorafenib. Clinical drug investigation, 2008, Volume: 28, Issue:12 Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Drug Eruptions; Erythema; Humans; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib	2008
Cutaneous drug eruptions induced by sorafenib: a case series. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Erythema; Female; Humans; Middle Aged; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib	2008
Non-pigmenting fixed drug eruption induced by sorafenib. Acta dermato-venereologica, 2010, Volume: 90, Issue:3 Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Biopsy; Carcinoma, Renal Cell; Drug Eruptions; Erythema; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Pyridines; Skin; Sorafenib	2010
Hyperkeratotic eruption, hand-foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib. International journal of dermatology, 2010, Volume: 49, Issue:10 Topics: Benzenesulfonates; Carcinoma, Renal Cell; Erythema; Humans; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Skin Diseases, Papulosquamous; Sorafenib; Stomatitis	2010
Erythema marginatum hemorrhagicum: a unique cutaneous side effect of sorafenib. Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:6 Topics: Aged; Benzenesulfonates; Carcinoma, Hepatocellular; Erythema; Hemorrhage; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Terminology as Topic	2011
Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma. Southern medical journal, 2007, Volume: 100, Issue:3 Topics: Acrodermatitis; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Erythema; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Protein Kinase Inhibitors; Pyridines; raf Kinases; Sorafenib; Spinal Neoplasms	2007
Localized palmar-plantar epidermal hyperplasia: a previously undefined dermatologic toxicity to sorafenib. The oncologist, 2007, Volume: 12, Issue:10 Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Drug Eruptions; Erythema; Humans; Kidney Neoplasms; Male; Niacinamide; Phenylurea Compounds; Pyridines; Receptors, Vascular Endothelial Growth Factor; Skin Diseases; Sorafenib	2007